Viewing Study NCT03568994


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2025-12-25 @ 11:56 PM
Study NCT ID: NCT03568994
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-11-21
First Post: 2018-05-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Atovaquone (MepronĀ®) Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML)
Sponsor: Baylor College of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module